ALS is a global provider of analytical testing and inspection services. While dominating the fragmented Australian market and being a large global player in commodity and environmental testing, it is ...
The availability of genetic testing for amyotrophic lateral sclerosis (ALS) for people with a family member diagnosed with the disease is expected to greatly increase the number of clinic visits to ...
Materials testing specialist ALS posted a 1% decline in underlying fiscal 2025 net profit after tax to AUD 293 million. It will raise up to AUD 390 million in a fully underwritten placement and share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results